Adrian von Witzleben

Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway

Adrian von Witzleben, Lukas T. Goerttler, Ralf Marienfeld et al. · Cancer Research · 2015 · 97 citations

Medicine, Oncology, Pharmacology +15

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li et al. · Nature · 2022 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15

In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival

Adrian von Witzleben, Lukas T. Goerttler, Jochen K. Lennerz et al. · European Spine Journal · 2015 · 34 citations

Medicine, Oncology, Pathology +16

HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas

Daniela Jäger, Thomas F.E. Barth, Silke Brüderlein et al. · Scientific Reports · 2017 · 30 citations · Full text

Medicine, Cell Biology, Oncology +16

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer

Katy J. McCann, Adrian von Witzleben, Jaya Thomas et al. · Journal for ImmunoTherapy of Cancer · 2022 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17